Article in Review: “Biotech Gets Personal,” by Ben Shepherd, February 22, 2012. Read More

Mortgage-backed securities remain a smart buy for low-risk income.   Read More

Despite rays of worldwide growth, Washington’s fiscal drama is casting a pall over the markets. Read More

Two Best Buys from our Growth and Income portfolios. Read More

The US recovery is lifting stocks, but investors are prudent to remain wary. Read More

Wise investors know when to fold a losing hand. We explain the right way to read the cards. Read More

Stocks in 2012 racked up their fourth win­ning year in a row. If there’s any truth to the old saw that the first six weeks portend the rest of the year, 2013 shouldn’t be too bad, either. Read More

Refiners will benefit the most from the shale oil boom. Here are our favorite plays. Read More

The bond market is at its most dangerous in decades, but there are still places of safety in this traditional haven. Read More